Altered retinoblastoma protein expression in nonsmall cell lung cancer

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Cancer

• Publication date

  1997-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/(SICI)1097-0142(19970401)79:7<1329::AID-CNCR9>3.0.CO;2-BPMID 9083154
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [New prognostic factors in lung cancer].

  1999cited by this paper
• The Molecular Biology of Lung Cancer

  1997cited by this paper
• Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers.

  1996cited by this paper
• Altered retinoblastoma and p53 protein status in non-small cell carcinoma of the lung: potential synergistic effects on prognosis.

  1996cited by this paper
• A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression.

  1995cited by this paper
• Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16

  1995cited by this paper
• New prognostic factors in lung cancer. Biologic prophets of cancer cell aggression.

  1995cited by this paper
• Molecular markers in early cancer detection. New screening tools.

  1995cited by this paper
• Mechanism of inactivation of CDKN2 and MTS2 in non-small cell lung cancer and association with advanced stage.

  1995cited by this paper
• Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines.

  1995cited by this paper
• Prognostic significance of p53 and ras p21 expression in nonsmall cell lung cancer

  1995cited by this paper
• Molecular and pathologic markers in stage I non-small-cell carcinoma of the lung.

  1995cited by this paper
• Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer.

  1994cited by this paper
• C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas.

  1994cited by this paper
• Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers

  1994cited by this paper
• A cell cycle regulator potentially involved in genesis of many tumor types.

  1994cited by this paper
• Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma.

  1994cited by this paper
• Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small-cell lung cancer.

  1993cited by this paper
• Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. The Lung Cancer Study Group.

  1993cited by this paper
• Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer.

  1993cited by this paper
• The molecular biology of lung cancer pathogenesis.

  1993cited by this paper
• Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer.

  1992cited by this paper
• Clinical significance of ras oncogene activation in human lung cancer.

  1992cited by this paper
• Prognostic significance of the expression of ras oncogene product in non‐small cell lung cancer

  1992cited by this paper
• Accumulation of p53 protein correlates with a poor prognosis in human lung cancer.

  1992cited by this paper
• Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer.

  1992cited by this paper
• Application of molecular genetics to the early diagnosis and screening of lung cancer.

  1992cited by this paper
• Molecular markers for the diagnosis and prognosis of lung cancer

  1992cited by this paper
• Absence of retinoblastoma protein expression in primary non-small cell lung carcinomas.

  1991cited by this paper
• Lack of nuclear RB protein staining in G0/middle G1 cells: correlation to changes in total RB protein level.

  1991cited by this paper
• Prognostic value of nuclear DNA content and expression of the ras oncogene product in lung cancer.

  1991cited by this paper
• p53 mutations in human cancers.

  1991cited by this paper
• Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group.

  1990cited by this paper
• Altered expression of the retinoblastoma gene product in human sarcomas.

  1990cited by this paper
• p53: a frequent target for genetic abnormalities in lung cancer.

  1989cited by this paper
• The retinoblastoma susceptibility gene product: a characteristic pattern in normal cells and abnormal expression in malignant cells.

  1989cited by this paper
• Abnormalities in structure and expression of the human retinoblastoma gene in SCLC.

  1988cited by this paper
• Structural evidence for the authenticity of the human retinoblastoma gene.

  1987cited by this paper
• Human retinoblastoma susceptibility gene: cloning, identification, and sequence

  1987cited by this paper
• A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma

  1986cited by this paper
• A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES.

  1965cited by this paper
• Bronchial Carcinoma

  1960cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Combinatorial In Vivo Genome Editing Identifies Widespread Epistasis and an Accessible Fitness Landscape During Lung Tumorigenesis

  2025cites this paper
• Relevance of pRB Loss in Human Malignancies

  2021cites this paper
• ATM/RB1 mutations predict shorter overall survival in urothelial cancer

  2018cites this paper
• Role of p38a in lung tumor progression

  2018cites this paper
• Molecular Basis of Lung Carcinogenesis

  2017cites this paper
• Genetic and molecular aspects of Helicobacter pylori in gastritis, pre- cancerous conditions and gastric adenocrcinoma

  2015cites this paper
• CD133 expression: a potential prognostic marker for non-small cell lung cancers

  2014cites this paper
• Molecular and Genetic Aspects of Lung Cancer

  2013cites this paper
• MET and phosphorylated MET as potential biomarkers in lung cancer.

  2011cites this paper
• Non-Neuroendocrine Carcinomas (Excluding “Sarcomatoid” Carcinoma) and Salivary Gland Analog Carcinomas in the Lung

  2011cites this paper
• Interaction of E 2 F / Rb Family Members with Factor Binding to Co-repressor Element on B-myb and E 2 F 1 Promoters

  2010cites this paper
• New biomarkers for lung cancer.

  2010cites this paper
• Molecular genetic abnormalities in the pathogenesis of human lung cancer

  2009cites this paper
• Combined detection of p53, p16, Rb, and EGFR mutations in lung cancer by suspension microarray.

  2009cites this paper
• Molecular genetics of lung and pleural neoplasms

  2008cites this paper
• Biomarkers in lung cancer: from early detection to novel therapeutics and decision making.

  2008cites this paper
• clinical implications Lung cancer • 9: Molecular biology of lung cancer:

  2007cites this paper
• RB activity alters checkpoint response and chemosensitivity in lung cancer lines.

  2007cites this paper
• Retinoblastoma deficiency increases chemosensitivity in lung cancer.

  2007cites this paper
• Expression and prognostic implications of apoptosis-related proteins in locally unresectable non-small cell lung cancers.

  2006cites this paper
• Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation

  2006cites this paper
• Inhibition of retinoblastoma tumor suppressor activity by RNA interference in lung cancer lines.

  2006cites this paper
• High rate of molecular alteration in histologically tumour-free bronchial epithelium of NSCLC patients detected by multicolour fluorescence in situ hybridisation.

  2006cites this paper
• Cytogenetic and molecular aspects of lung cancer.

  2006cites this paper
• Biomarker profiling for cancer diagnosis, prognosis and therapeutic management.

  2005cites this paper
• Mouse models for human lung cancer.

  2005influential citation
• Expression of retinoblastoma and p53 pathway-related proteins in resectable invasive ductal carcinoma of the pancreas: potential cooperative effects on clinical outcome.

  2005cites this paper
• Overexpression of the Aldo-Keto Reductase Family Protein AKR1B10 Is Highly Correlated with Smokers' Non–Small Cell Lung Carcinomas

  2005cites this paper
• The prospect of biologic staging of non-small-cell lung cancer.

  2005cites this paper
• Loss of heterozygosity patterns provide fingerprints for genetic heterogeneity in multistep cancer progression of tobacco smoke-induced non-small cell lung cancer.

  2005cites this paper
• Genotype-phenotype relationships in a mouse model for human small-cell lung cancer.

  2005cites this paper
• The prospect of biologic staging of non-small-cell lung cancer

  2005cites this paper
• Pineal parenchymal tumours: II. On the aggressive behaviour of pineoblastoma in patients with an inherited mutation of the RB1 gene.

  2004cites this paper
• Pineal parenchymal tumours: I. Pineocytoma: a tumour responsive to platinum-based chemotherapy.

  2004cites this paper
• Biomarkers in non-small cell lung cancer prevention

  2004cites this paper
• Validation of molecular and immunological factors with predictive importance in lung cancer.

  2004cites this paper
• Overexpressions of Ha-ras and p53 predict the prognosis of patients with non-small-cell lung carcinoma

  2004cites this paper
• Prognostic Relevance of Altered pRb and p53 Protein Expression in Surgically Treated Non-Small Cell Lung Cancer Patients

  2004cites this paper
• The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis

  2004cites this paper
• MBD genes and Hedgehog signalling in cancer

  2004cites this paper
• Lung cancer • 9: Molecular biology of lung cancer: clinical implications

  2003cites this paper
• The clinical relevance of Bcl-2, Rb and p53 expression in advanced non-small cell lung cancer.

  2003cites this paper
• Comparison of automated cellular imaging system and manual microscopy for immunohistochemically stained cryostat sections of lung cancer specimens applying p53, ki-67 and p120.

  2003cites this paper
• Investigation of c-myc and p53 Gene Alterations in the Tumor and Surgical Borderline Tissues of NSCLC and Effects on Clinicopathologic Behavior: By the FISH Technique

  2003cites this paper
• Helicobacter pylori infection generated gastric cancer through p53-Rb tumor-suppressor system mutation and telomerase reactivation.

  2003cites this paper
• Identification of the novel role of pRB in eye cancer

  2003cites this paper
• Alterations of tumor suppressor genes (Rb, p16, p27 and p53) and an increased FDG uptake in lung cancer

  2003cites this paper
• Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis

  2003cites this paper
• Molecular biology of lung cancer: clinical implications.

  2002cites this paper
• Molecular Biology of Human Lung Cancer

  2002cites this paper
• Biologia do cancro do pulmão: conceitos actuais

  2002cites this paper
• The Molecular Basis of Lung Carcinogenesis

  2002cites this paper
• RCAS1 Expression: A Potential Prognostic Marker for Adenocarcinomas of the Lung

  2002cites this paper
• Molecular Pathogenesis of Lung Cancer

  2002cites this paper
• Increased expression of beta-catenin predicts better prognosis in nonsmall cell lung carcinomas.

  2002cites this paper
• Clinical significance of P16INK4A and retinoblastoma proteins in non-small-cell lung carcinoma.

  2002cites this paper
• 15 - Immunohistochemistry of BCL-2 Gene Expression in Lung Carcinoma

  2002cites this paper
• [2000 Standards, Options and Recommendations for prognostic value of oncogenes and tumor suppressor genes in non small cell lung cancer].

  2002cites this paper
• Blood vessel invasion in resected non small cell lung carcinomas is predictive of metastatic occurrence.

  2002cites this paper
• Molekulare Pathologie bösartiger pulmonaler und pleuraler Tumoren

  2002cites this paper
• Molecular Biology of Lung Cancer

  2002cites this paper
• Molecular biology of lung cancer: clinical implications.

  2002cites this paper
• Increased expression of β‐catenin predicts better prognosis in nonsmall cell lung carcinomas

  2002cites this paper
• The role of apoptosis-related genes in non-small-cell lung cancer.

  2002cites this paper
• Prognostic factors in non-small cell lung cancer: a decade of progress.

  2002cites this paper
• Prognostic factors in nonsmall cell lung cancer

  2002cites this paper
• Prognostic factors in betel and tobacco related oral cancer.

  2002cites this paper
• Differential expression of critical cellular genes in human lung adenocarcinomas and squamous cell carcinomas in comparison to normal lung tissues.

  2002cites this paper
• Loss of p16 and/or pRb protein expression in NSCLC. An immunohistochemical and prognostic study.

  2001cites this paper
• Expressão imunohistoquímica da proteína pRb na mucosa esofágica de indivíduos sob risco para carcinoma epidermóide de esôfago

  2001cites this paper
• Prognostic molecular markers in non-small cell lung cancer.

  2001cites this paper
• Prognostic factors in stage I/II non-small cell lung cancer.

  2001cites this paper
• G1 phase of the cell cycle control and lung cancer: biological and clinical implications. Minireview.

  2001cites this paper
• Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis.

  2001cites this paper
• Clinical significance of the Rb expression in adenocarcinoma of the lung.

  2001cites this paper
• Promoter Hypermethylation of the RB1 Gene in Glioblastomas

  2001cites this paper
• Prognostic significance of percentage of bronchioloalveolar pattern in adenocarcinomas of the lung.

  2001cites this paper
• Prognostic significance of p21waf1, cyclin D1 and retinoblastoma expression detected by immunohistochemistry in non-small cell lung cancer.

  2001cites this paper
• A risk-stratification model of non-small cell lung cancers using cyclin E, Ki-67, and ras p21: different roles of G1 cyclins in cell proliferation and prognosis.

  2001cites this paper
• Altered Expression of the Cell Cycle Regulatory Molecules pRb, p53 and MDM2 Exert a Synergetic Effect on Tumor Growth and Chromosomal Instability in Non-small Cell Lung Carcinomas (NSCLCs)

  2000cites this paper
• Combined analysis of p53 and retinoblastoma protein expressions in esophageal cancer.

  2000cites this paper
• [Pathology and molecular biology of lung cancer].

  2000cites this paper
• The RB 2 / p 130 Gene : The Latest Weapon in the War against Lung Cancer ? 1

  2000cites this paper
• Prognostic Significance of p 27 KIP 1 Protein and Ki-67 Growth Fraction in Non-small Cell Lung Cancers

  2000cites this paper
• Pathologie und Molekularbiologie bösartiger pulmonaler Tumoren

  2000cites this paper
• Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers.

  2000cites this paper
• Analysis of K-Ras Oncogene Codon 12 Mutations in a Series of Human Lung Cancers

  2000cites this paper
• The retinoblastoma gene family: its role in cancer onset and progression

  2000cites this paper
• The biology of lung cancer including potential clinical applications.

  2000cites this paper
• The RB2/p130 gene: the latest weapon in the war against lung cancer?

  2000cites this paper
• Cyclin E expression, a potential prognostic marker for non-small cell lung cancers.

  2000cites this paper
• Retinoblastoma‐protein (prb) expression and prognosis in squamous‐cell carcinomas of the esophagus

  1999cites this paper
• p16 inactivation in small‐sized lung adenocarcinoma: Its association with poor prognosis

  1999cites this paper
• A correlation of APC and c-myc mRNA levels in lung cancer cell lines.

  1999cites this paper
• Predictive value of expression of p16INK4A, retinoblastoma and p53 proteins for the prognosis of non-small-cell lung cancers

  1999cites this paper
• Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers.

  1999cites this paper
• Alterations of INK4A and INK4B genes in adult soft tissue sarcomas: effect on survival.

  1999cites this paper
• Prognosis for G1 cell‐cycle regulators: useful for predicting course of disease and for assessment of therapy in cancer

  1999cites this paper
• Alterations of expression of Rb, p16INK4A and cyclin D1 in non‐small cell lung carcinoma and their clinical significance

  1999cites this paper
• Prognostic Factors: From Clinical Parameters to New Biological Markers

  1999cites this paper